Priovant
Ben Zimmer is the current CEO at Priovant. Prior to this, they were the President at Roivant Sciences from January 2015 to October 2021. Before that, they were the Executive Director at the Connecticut Policy Institute from September 2011 to January 2015. Their first job out of college was as a Business Analyst at McKinsey & Company from July 2007 to June 2009.
Ben Zimmer attended Harvard University for their A.B. and Yale Law School for their J.D.
This person is not in any offices
Priovant
2 followers
Priovant Therapeutics is a clinical-stage biotechnology company focused on delivering novel therapies for autoimmune diseases with the heaviest patient burdens.